Pluri Inc. (PLUR)
NASDAQ: PLUR · Real-Time Price · USD
0.9400
-0.0298 (-3.07%)
At close: Nov 20, 2026, 4:00 PM EST
0.9900
+0.0500 (5.32%)
After-hours: Nov 20, 2026, 6:28 PM EST
Pluri Market Cap
Pluri has a market cap or net worth of $13.51 million as of November 20, 2026. It is the 39,177th most valuable company in the world and the 5,307th biggest in the United States. Its market cap has decreased by 59.05% in one year.
Market Cap
13.51M
Enterprise Value
40.31M
1-Year Change
-59.05%
Global Rank
Country Rank
#5,307 United States
Category
ChartMarket Cap Chart
Since December 10, 2007, Pluri's market cap has decreased from $36.10M to $13.51M, a decrease of -62.57%. That is a compound annual growth rate of -5.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 13.50M | -51.26% |
| Dec 31, 2025 | 27.70M | 16.39% |
| Dec 31, 2024 | 23.80M | -0.83% |
| Dec 29, 2023 | 24.00M | -21.82% |
| Dec 30, 2022 | 30.70M | -34.54% |
| Dec 31, 2021 | 46.90M | -74.12% |
| Dec 31, 2020 | 181.20M | 192.73% |
| Dec 31, 2019 | 61.90M | -32.20% |
| Dec 31, 2018 | 91.30M | -38.81% |
| Dec 29, 2017 | 149.20M | 28.73% |
| Dec 30, 2016 | 115.90M | 29.35% |
| Dec 31, 2015 | 89.60M | -48.86% |
| Dec 31, 2014 | 175.20M | -16.89% |
| Dec 31, 2013 | 210.80M | 15.13% |
| Dec 31, 2012 | 183.10M | 67.98% |
| Dec 30, 2011 | 109.00M | 189.89% |
| Dec 31, 2010 | 37.60M | 74.88% |
| Dec 31, 2009 | 21.50M | 532.35% |
| Dec 31, 2008 | 3.40M | -84.62% |
| Dec 31, 2007 | 22.10M | -38.78% |
| Dec 10, 2007 | 36.10M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Akari Therapeutics, | 15.33M |
| Celularity | 15.18M |
| Estrella Immunopharma | 14.81M |
| Acumen Pharmaceuticals | 13.98M |
| Allarity Therapeutics | 13.76M |
| Citius Pharmaceuticals | 13.65M |
| Seres Therapeutics | 13.56M |
| Bolt Biotherapeutics | 13.19M |